Rethinking Cell Therapeutics… As An Acquirer? (CTICD)

---

Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock.  It has brought many rewards for investors and it has also brought much pain to investors.  We recently featured its positive development in pixantrone with an appeal at the FDA that will allow it to resubmit a new drug application.  Keep in mind that [...]

[[ This is a...



[[ This is a content summary only. Visit my website for full links, other content, and more! ]]